Trials / Conditions / SLE (Systemic Lupus)

SLE (Systemic Lupus)

21 registered clinical trials studyying SLE (Systemic Lupus) — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics NCT07516639	SUNHO（China）BioPharmaceutical CO., Ltd.	Phase 1
Not Yet Recruiting	Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus NCT07364396	Curocell Inc.	Phase 1 / Phase 2
Recruiting	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evalu NCT07260877	Ventus Therapeutics U.S., Inc.	Phase 2
Active Not Recruiting	A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain NCT07196072	University of Michigan	N/A
Completed	Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA NCT07237659	Neutrolis	Phase 1
Not Yet Recruiting	Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia NCT06971913	Peking University People's Hospital	Phase 2
Recruiting	A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease NCT06925542	CRISPR Therapeutics	Phase 1
Recruiting	A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupu NCT06613360	Cullinan Therapeutics Inc.	Phase 1
Not Yet Recruiting	Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity NCT06610409	Assiut University	—
Recruiting	Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases NCT06548607	Nanjing Bioheng Biotech Co., Ltd.	EARLY_Phase 1
Terminated	Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging) NCT06445127	Johns Hopkins University	—
Active Not Recruiting	Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) NCT06294236	Sana Biotechnology	Phase 1
Completed	Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus. NCT06150651	Chulalongkorn University	Phase 1
Unknown	Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients NCT06063668	Assiut University	—
Recruiting	Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease NCT06056921	Chongqing Precision Biotech Co., Ltd	Phase 1
Active Not Recruiting	A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus NCT05866861	Cugene Inc.	Phase 1
Completed	Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients NCT06560775	University of Brawijaya	N/A
Completed	BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus NCT05624437	Centre Hospitalier de Niort	—
Unknown	Posterior Segment Evaluation of Patients With SLE Using OCT and OCTA NCT04866615	Minia University	—
Unknown	Clinical Characteristic and MEFV Gene Mutations in Patient With Juvenile Onest Systemic Lupus Erythematosus NCT04645225	Assiut University	—
Recruiting	National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia NCT04604990	King Saud University	—